This post has been archived and contains information that may be out of date.
Beginning Feb. 23, the Department of Health Care Services (DHCS) will implement a new fee-for-service reimbursement methodology for covered outpatient drugs. The methodology will reimburse the lower of the actual acquisition cost (as determined by the Centers for Medicare & Medicaid Services), the federal upper limit, the maximum allowable ingredient cost, and the pharmacy’s usual and customary charge. For more details about the changes, visit the DHCS website.
